---
source: Differential Diagnosis in Small - Gough, Alex, Murphy, Kate.pdf
pages: 463
converted: 2026-02-01 19:52
part: chunk_025
estimated_tokens: 2061
---



sneezing and nasal discharge
anatomical deformities, 53
congenital disease, 53
dental disease, 53
infection, 53–4
inflammatory disease, 54
neoplasia, 54
physical, 54
systemic disease, 54
spinal disease, 18, 20–21, 48, 130,
189, 205, 392
congenital, 76
degenerative, 76
idiopathic, 76
immune mediated, 77
infectious, 77
neoplastic, 77
nutritional, 77
traumatic, 78
vascular, 78
spinal disorders
C1-C5, 190–191
cranial to L7, 209
C6-T2, 191
L4-S3, 192
T3-L3, 191–2
spine radiography
acquired variation, vertebral shape
and size, 283–5
contrast radiography (myelography),
287–9
intervertebral space, abnormalities,
286–7
normal and congenital variation,
vertebral shape and size,
282–3
vertebral radiopacity, changes,
285–6
spleen, abdominal radiography
absence, 241
enlargement, 239–40
reduction in size, 241


Index 443



splenic disease, abdominal
ultrasonography
diffuse splenic disease,
splenomegaly, 300
focal/multifocal splenic disease,
300–301
splenic mass, 261
splenomegaly, 9, 138, 245, 250, 261,
300–301, 353
stomach, abdominal radiography
abnormal contents, 241–2
caudal displacement, 242
cranial displacement, 242
delayed gastric emptying, 242–3
distended, 243–4
increased wall thickness, 244
S–T segment alterations
depression/slur, 414–15
elevation, 415
pseudo-depression, 415
secondary changes, 415
syncope/collapse
cardiovascular dysfunction, 14–15
drugs, 15
hypoxaemic disease, 15–16
metabolic/endocrine disorders, 16
myopathies, 16–17
neurological dysfunction, 17–18
skeletal/joint disorders, 18


tachyarrhythmias, 15, 18, 163, 164, 291
tachycardia, 15, 18, 156, 157, 412,
413, 415, 418
drugs/toxins, 161–2
sinus, 162, 420–421
supraventricular, 15, 18, 162, 413,
418, 420
ventricular, 15, 18, 162, 412, 413,
418–19, 420
testes, ultrasonography
enlargement, 308
focal lesions, neoplasia, 309



testicular abnormalities
large testis, 211
no palpable testis, 211
single palpable testis, 211
small testis, 211
testosterone, 406
thoracic radiography
alveolar pattern (increased)
atelectasis, 214–15
inflammation/immune
mediated, 215
neoplasia, 215
pneumonia, 215–16
pulmonary haemorrhage, 216
pulmonary oedema, 216–17
pulmonary thromboembolism, 217
bronchial pattern (increased)
bronchial wall oedema, 214
bronchiectasis, 214
chronic bronchitis, 214
normal variation, 213
cardiac silhouette
decreased size, 223–4
diseases, 222
generalised cardiomegaly, 222–3
increased size, 222–3
diaphragm abnormalities, 233–4
interstitial pattern (increased)
diffuse/unstructured, 218–19
nodular, 217–18
reticular pattern, 220
lung opacity (increased), 213
mediastinal abnormalities
air from neck, 236
masses, 234–5
mediastinal shift, 235–6
pneumomediastinum, 236
widened mediastinum, 236–7
oesophagus abnormalities, 225–8
pleural effusion, 230–232
pneumothorax, 232
rib abnormalities, 224–5


444 Index



thoracic radiography ( _cont’d_ )
tracheal abnormalities, 228–30
vascular pattern (increased)
pulmonary arteries, 220
pulmonary veins, 220
thoracic ultrasonography
altered chamber dimensions, 291–3
changes in ejection phase indices, 294
mediastinal masses, 290
pericardial effusion, 290–291
pleural effusion, 289
thrombocytopathia, 40, 42, 55, 58, 117
thrombocytopenia, 40, 42, 44, 55, 58,
117, 122, 230, 330, 354, 362
decreased production, 350–351
immune-mediated destruction, 351–2
sequestration, 353
utilization (increased)/non-immune
destruction, 352–3
thrombocytosis
normal, 353
post splenectomy, 353
reactive, 353–4
rebound, 354
splenic contraction, 353
thyroxine, 401–3
tracheal abnormalities
dorsal displacement, 228
lateral displacement, 228
narrowing, 229
opacification, lumen, 229–30
ventral displacement, 228
tracheal/bronchoalveolar lavage
eosinophils (increased), 392–3
neutrophils (increased), 392
organisms visible on microscopy/
detectable on culture, 393–4
trembling/shivering
drugs/toxins, 65–6
metabolic, 66
neurological, 66–7
physiological, 67



tremors/shivering, 325
trigeminal nerve, lesions, 193, 200
triglycerides, 336
trismus
drugs/toxins, 206
inflammatory, 206
mechanical, 206
pain on opening jaw, 206–7
temporomandibular joint
ankylosis, 207
troponin, 337–8
trypsin-like immunoreactivity, 338
T waves, 416
tympanic bulla, head and neck
radiography, 276–7


ultrasonography
eyes, 309–10
neck, 311–12
testes, 308–9
undigested food residues
fat, 409
starch, 409
uraemia, 34, 38, 40–43, 66, 68, 82,
124, 136, 137, 161, 188, 217,
219, 242, 262, 291, 304, 344,
352, 363, 392, 419
encephalopathy, 68, 82, 188
gastritis, 262, 304
urea
acute kidney injury, 338–40
chronic kidney disease, 340
decreased, 340–341
increased, 338
post-renal, 340
ureters, abdominal radiography, 251
urethra, abdominal radiography
contrast medium leakage,
254–5
displacement, 255
filling defects, 255
strictures/irregular surface, 255


Index 445



urinary bladder
abdominal radiography
abnormal bladder contents, 251–2
abnormal shape, 252
decreased opacity, 253
displacement, 252
enlarged bladder, 252–3
failure to distend, 252
increased opacity, 253–4
non-visualisation, 254
small bladder, 253
thickening of wall, 254
disease, abdominal ultrasonography,
302–3
distended, 119, 137, 139, 261
enlarged, 245, 249, 250, 252
large, 209
palpable mass, 208
palpate, 209–10
urinary incontinence/inappropriate
urination
with bladder distension, 119
without bladder distension,
119–20
urine chemistry, abnormalities
bilirubin, 383
blood, 383
glucose, 383–4
haemoglobin, 384
ketones, 384
myoglobin-muscle injury/necrosis,
384–5
nitrite, 385
pH, decreased, 387
pH, increased, 387–8
protein, 385–7
urobilinogen, 388
urine sediment, abnormalities
crystals (predisposing factors),
388–90
red blood cells (increased), 390
white blood cells (increased), 390



urogenital physical signs
bladder abnormalities, 208–10
kidneys abnormal, palpation, 207–8
penis abnormalities, 211–12
prostate abnormal on palpation, 210
testicular abnormalities, 211
uterus abnormal on palpation, 210
urological historical signs
anuria/oliguria, 116
haematuria, 117–18
pollakiuria/dysuria/stranguria, 115
polyuria/polydipsia, 115–16
urinary incontinence/inappropriate
urination, 119–20
uterine enlargement, 9
uterus
abdominal radiography, 261
enlarged, 138, 245, 247, 249, 250,
252, 262
enlargement on palpation, 210
uveitis, 198, 202, 203
acute, 94
anterior, 91, 197, 204
idiopathic, 194
infection, 194–5
ionising radiation, 194
neoplasia, 195
non-infectious inflammatory, 196
systemic, 196
trauma, 196
chronic, 91, 92, 201


vaginal/vulval discharge, 111
vertebral malformations, 71, 76, 282,
284, 285, 286
vestibular disease, 17, 18, 20, 21, 32, 185
central vestibular system, 188–9
congenital
drugs/toxins, 186–7
idiopathic conditions, 187
infection, 188
metabolic disease, 188


446 Index



vestibular disease ( _cont’d_ )
neoplasia, 188
trauma, 188
lesions (circling), 85
peripheral, 186–8
congenital, 70
drugs/toxins, 70
idiopathic, 70
immune mediated/infectious, 70
metabolic, 70
neoplastic, 71
traumatic, 71
vitamin A
deficiency, 92, 93
responsive dermatosis, 61,
165, 176
vitamin B12 (cobalamin),
341, 347
vitamin C, 389
vitamin D
(1,25-dihydroxycholecalciferol)
decreased, 405–6
deficiency, 374
increased, 406
rodenticides, 6, 31, 38, 65, 151, 161,
162, 413, 419, 421, 422
vitamin E deficiency, 92, 325, 335
vomiting, 1, 6, 23, 133, 152, 215, 349,
368, 373, 375, 376, 378
acute
dietary, 28
drugs/toxins, 29–31
endocrine disease, 31
gastrointestinal disease, 31–2
metabolic/systemic disease, 32



chronic
endocrine disease, 32
gastrointestinal disease, 32–3
metabolic/systemic disease, 33
gastrointestinal loss, 371
weight loss, 8


weakness, 207
cardiovascular diseases, 18
drugs/toxins, 18–19
endocrine diseases, 19
haematological diseases, 19
infectious diseases, 19
inflammatory/immune-mediated
diseases, 19
metabolic disease, 20
neurological diseases, 20–21
nutritional disorders, 21
physiological factors, 21
respiratory diseases, 21
systemic disorders, 21
weight gain
body fat (increased), 9
decreased energy utilisation, 9
fluid accumulation, 9
neoplasia, 9
organ size (increased), 9
weight loss
decreased nutrient intake, 7
maldigestion/malabsorption, 8
nutrient loss (increased), 8
nutrient use (increased), 8
regurgitation and vomiting, 8


zinc, 341


**WILEY END USER LICENSE AGREEMENT**


Go to www.wiley.com/go/eula to access Wiley’s ebook EULA.


